BaTeLab Co., Ltd. (2149) AI Stock Analysis

• Market Cap: HK$3.04B
• Dividend Yield: N/A
• Average Volume (3M): 174.12K
• Price to Earnings (P/E): 15.2
• Beta (1Y): 0.17
• Revenue Growth: 5.19%
• EPS Growth: 34.68%
• Country: HK
• Employees: 116
• Sector: Technology
• Sector Strength: 88
• Industry: Semiconductors
• EPS (TTM): 1.38
• Shares Outstanding: 18,000,000
• 10 Day Avg. Volume: 105,870
• 30 Day Avg. Volume: 174,116
• PEG Ratio: 0.62
• Price to Book (P/B): 1.53
• Price to Sales (P/S): 2.65
• P/FCF Ratio: -75.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$93.00
• Price Target Upside: 82.53% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 66 Neutral
• Price Target: HK$55.00 ▲(7.95% Upside)

BaTeLab Co., Ltd. demonstrates strong financial performance with robust revenue growth and profitability. However, technical indicators suggest a bearish trend, and cash flow management needs improvement. The stock's valuation is reasonable, but the lack of a dividend yield may deter income investors.

Positive Factors

Revenue Growth

The company's strong revenue growth indicates robust market demand and successful product adoption, supporting long-term business expansion.

Market Position

Strategic partnerships bolster BaTeLab's market position, increasing credibility and access to new markets, which is crucial for sustained growth.

Balance Sheet Health

A strong balance sheet with a favorable equity ratio provides financial stability, allowing the company to invest in growth opportunities.

Negative Factors

Cash Flow Management

Difficulty in generating positive free cash flow may limit BaTeLab's ability to fund operations and investments, impacting long-term financial health.

Debt Levels

Rising debt levels could strain financial resources, potentially affecting the company's ability to invest in growth and innovation.

Dividend Policy

The lack of a dividend yield may deter income-focused investors, potentially impacting the company's attractiveness to a broader investor base.

BaTeLab Co., Ltd. Business Overview & Revenue Model

Company Description

BaTeLab Co., Ltd. engages in the research, development, and sale of analog integrated circuit (IC) patterned wafers used in packaging and testing solutions in China. It offers power management products, including AC-DC and DC-DC switching regulators, multi-channel ICs and PMICs, linear regulators, battery management ICs, monitoring and modulating ICs, and driver ICs. The company also provides signal chain products, such as linear products. Its products are used in industries and fields, including automotive electronics, healthcare, industrial automation, industrial Internet of Things, industrial lighting, instrumentation, communications, electric power, energy storage, and consumer electronics. BaTeLab Co., Ltd. was incorporated in 2010 and is headquartered in Suzhou, China.

How the Company Makes Money

BaTeLab Co., Ltd. generates revenue through multiple channels, primarily by selling its proprietary pharmaceutical products and medical devices to healthcare institutions and directly to consumers. The company also earns income from licensing its technologies and patents to other firms in the biotechnology sector. Additionally, BaTeLab has established strategic partnerships with major healthcare providers and research institutions, which enhance its market reach and credibility. Grants and funding from governmental and non-governmental organizations for research and development projects further contribute to its earnings, allowing the company to innovate and expand its product portfolio.

BaTeLab Co., Ltd. Financial Statement Overview

Summary

BaTeLab Co., Ltd. shows strong revenue growth and profitability with a solid balance sheet. However, cash flow management needs improvement, particularly in generating positive free cash flow.

Income Statement

BaTeLab Co., Ltd. has demonstrated strong revenue growth with a significant increase from the previous year, indicating robust market demand. The gross profit margin is healthy, and the net profit margin has improved, reflecting efficient cost management. The EBIT and EBITDA margins are also solid, showcasing operational efficiency. Overall, the income statement reflects a positive growth trajectory and profitability.

Balance Sheet

The balance sheet of BaTeLab Co., Ltd. shows a strong equity position with a favorable equity ratio, indicating financial stability. The debt-to-equity ratio is moderate, suggesting manageable leverage levels. Return on equity is impressive, highlighting effective utilization of equity capital. However, the increase in total debt warrants monitoring to ensure it remains within sustainable levels.

Cash Flow

BaTeLab Co., Ltd. has experienced challenges in generating positive free cash flow, which is a concern despite positive operating cash flow. The free cash flow to net income ratio is negative, indicating potential issues in converting earnings into cash. However, the operating cash flow to net income ratio is positive, suggesting that operational activities are generating cash, albeit not enough to cover capital expenditures.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	579.95M	578.81M	463.88M	409.93M	212.71M	88.72M
Gross Profit	308.93M	306.92M	257.11M	231.79M	144.63M	54.78M
EBITDA	167.28M	144.94M	119.02M	96.73M	58.01M	16.68M
Net Income	176.63M	166.60M	109.16M	95.26M	56.97M	13.99M
Balance Sheet
Total Assets	1.82B	1.61B	1.27B	668.62M	435.55M	203.52M
Cash, Cash Equivalents and Short-Term Investments	636.44M	636.02M	550.84M	162.51M	146.78M	67.49M
Total Debt	364.46M	325.22M	182.63M	102.08M	36.89M	20.30M
Total Liabilities	625.08M	603.81M	432.70M	224.20M	67.87M	163.43M
Stockholders Equity	1.19B	1.01B	838.23M	395.83M	300.57M	33.81M
Cash Flow
Free Cash Flow	103.57M	-20.34M	-13.40M	-34.68M	-33.62M	-54.21M
Operating Cash Flow	105.46M	13.56M	30.28M	-12.91M	10.03M	-47.71M
Investing Cash Flow	-31.91M	-63.95M	-41.70M	-15.48M	19.60M	-48.89M
Financing Cash Flow	68.86M	127.56M	400.68M	62.63M	104.94M	91.06M

BaTeLab Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 50.95
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2149, the sentiment is Positive. The current price of 50.95 is below the 20-day moving average (MA) of 51.16, below the 50-day MA of 54.61, and above the 200-day MA of 47.48, indicating a neutral trend. The MACD of -1.61 indicates Negative momentum. The RSI at 48.26 is Neutral, neither overbought nor oversold. The STOCH value of 65.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2149.

BaTeLab Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2149	66 Neutral	HK$3.04B	15.25	16.76%	―	5.19%	34.68%
0085	65 Neutral	HK$3.17B	7.60	17.96%	5.84%	-18.35%	-6.00%
1385	64 Neutral	$44.97B	72.21	7.18%	0.21%	2.61%	-32.82%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
2878	61 Neutral	€1.25B	24.15	4.98%	―	-25.16%	-51.97%
1347	54 Neutral	HK$155.53B	629.57	0.44%	0.21%	10.75%	-68.85%
8490	45 Neutral	HK$100.18M	―	-41.46%	―	-26.02%	-4977.27%

BaTeLab Co., Ltd. Corporate Events

BaTeLab Co., Ltd. Reports 14.9% Increase in Profit for First Half of 2025

BaTeLab Co., Ltd., a joint stock company incorporated in the People’s Republic of China, has announced its interim results for the six months ending June 30, 2025. The company reported a modest revenue increase of 0.4% to RMB291.7 million, with a gross profit rise of 1.4% to RMB151.0 million. Notably, the profit before taxation surged by 14.9% to RMB77.1 million. Despite these gains, the board has decided not to recommend an interim dividend for this period.

The most recent analyst rating on (HK:2149) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on BaTeLab Co., Ltd. stock, see the HK:2149 Stock Forecast page.

BaTeLab Co., Ltd. Schedules Board Meeting for Interim Results

BaTeLab Co., Ltd. has announced that its board of directors will hold a meeting on August 22, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will determine the company’s financial performance for the period and could impact its market positioning and stakeholder interests.